This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.
Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain riskfactors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology.
Research Highlights: A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options. What is Atrial Fibrillation?
A Cedars-Sinai-led team developed an echocardiography AI model that accurately detects patients with atrial fibrillation – including asymptomatic patients – potentially revealing a new “opportunistic screening” method to drive earlier AFib detection and treatment. AUC identifying patients with a history of AFib.
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Affecting 60 million people worldwide 1 , the prevalence of atrial fibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic riskfactors 2. Today, 40% to 60% of patients with AFib are either not prescribed anticoagulants or are undertreated 4.
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial fibrillation (AFib) burden or progression when compared with standard care, according to preliminary late-breaking science presented Nov. 18 at the American Heart Association's Scientific Sessions 2024.
The ACC and the American Heart Association (AHA) guideline for the management of atrial fibrillation (AFib) provides a comprehensive multi-society update, the first in a decade, and offers a new staging system for AFib, upgrades recommendations for catheter ablation, rhythm control and left atrial appendage occlusion (LAAO), and emphasizes the importance (..)
Detection of Irregular Heart Rhythms Devices such as the Apple Watch or Fitbit Sense can detect irregular heart rhythms, including atrial fibrillation (AFib). These early warnings are critical, as AFib increases the risk of stroke and other heart-related complications.
The results support the use of workflows to reduce radiation exposure during catheter ablation for the treatment of paroxysmal atrial fibrillation (AFib) while maintaining safety, efficacy, and long-term patient outcomes comparable to traditional procedures.1 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1
Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and riskfactors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrial fibrillation (AFib) ablation in patients with heart failure with (..)
And since common things are common, the statistical probability favors Atrial Fibrillation (AFib) as the culprit. AFib can come and go. The technical term here is paroxysmal AFib (PAF). In general, the longer an AFib episode the more increased risk of stroke. We do have the ECG. But the ECG is Sinus!
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).
Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. If you or someone you know is living with AFib, understanding the condition and how to prevent attacks is crucial. What Is AFib? How Do You Know If You Have AFib?
Syncope without prodrome is a significant riskfactor for cardiac syncope and poor outcome. Many patients have a T achy- B rady syndrome in which tachyarrhythmias ( most commonly rapid AFib ) alternate with periods of bradycardia. New slow AFib reflects a combination of these rhythm problems. Learning Points: 1.
Is longterm endurance-training a riskfactor for AFib and AFlutter? == Why is Today's Initial Rhythm AFlutter? Moderate" exercise seems to have a protective effect with reduced risk of AFib — whereas "excessive" exercise has been shown to significantly increase the risk of developing AFib, especially as adults age.
That preventative focus seems to be bringing an embrace of a wider range of riskfactors and risk detection methods (well beyond blood pressure and LDL-C). Depending on who you talk to, we could be headed towards a completely new anticoagulation standard of care.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. In the U.S.,
America Has CKM Syndrome – The vast majority of Americans are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome. AFib Wakeup Call – A JACC study suggested that atrial fibrillation is far more prevalent than many thought. A JAMA analysis of 11k adults revealed that only 10.6% If applied across the U.S.,
So, how can you lower your risk for heart attacks, heart disease and other complications? Dr. Schuitema and cardiologist Dr. Daniel Tarditi explain the riskfactors, how to keep the holidays as “heart-friendly” as possible and avoid unnecessary trips to the emergency room.
Introduction:Atrial fibrillation (AFib) is a major riskfactor for ischemic stroke (IS). Our outcome was differentially expressed levels of proteins in stroke patients with AFib compared to patients without AFib. years, 50% males) classified into 11 AFib and 49 no AFib (Figure 1).
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists. In patients who are not taking statins, Esperion announced that bempedoic acid with or without ezetimibe (Nexletol/Nexlizet) can lower LDL cholesterol by more than 25%.
Image courtesy: Getty Images christine.book Sat, 05/18/2024 - 14:26 May 18, 2024 — The Heart Rhythm Society ( HRS ) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation ( AFib ). doi:10.1001/jama.285.18.2370
All in all there have been more than 14 studies which have looked at this association and most have confirmed this finding so it is highly likely that this is not just coincidental Could it be because AF and dementia share the same riskfactors rather than specifically because the AF is causing the dementia?
AFib Facts and Impacts Atrial fibrillation is the most common cardiac arrhythmia, affecting 2% of individuals worldwide. 50 year trends in atrial fibrillation prevalence, incidence, riskfactors, and mortality in the Framingham Heart Study: a cohort study. 7 Atrial fibrillation has a significant impact on people’s lives.
They measured QTc while patients were in Afib and then again after conversion, when they were in sinus rhythm. They found that Bazetts formula overestimated QTc in Afib while Fridericias formula was the most accurate. The RR interval was also a 10 second average. Am J Cardiol 12(9):1379-1383; Nov 2013.
Furthermore, it includes the latest recommendations which specifically address AF and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, AF catheter or surgical ablation, and riskfactor modification and AF prevention.
The total person-time of follow-up was 7 380 304 person-years, during which there were 2483 (0.3%) incident AFib diagnoses and 2951 (0.4%) deaths. The total person-time of follow-up was 7 380 304 person-years, during which there were 2483 (0.3%) incident AFib diagnoses and 2951 (0.4%) deaths.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content